Tabernero, J., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., . . . Kopetz, S. (2021). Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study. J Clin Oncol.
Citação norma ChicagoTabernero, Josep, et al. "Encorafenib Plus Cetuximab As a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses From the BEACON Study." J Clin Oncol 2021.
MLA引文Tabernero, Josep, et al. "Encorafenib Plus Cetuximab As a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses From the BEACON Study." J Clin Oncol 2021.